Summary
Evaluation of the Efficacy and Safety of Oral Azacitidine plus Best Supportive care versus
Placebo and Best Supportive care in subjects with red blood cell (RBC) transfusion-dependent
anemia and thrombocytopenia due to International Prognostic Scoring System (IPSS) lower risk
myelodysplastic syndromes (MDS).